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Abstract  
Background: Diagnostic errors are an important source of preventable harm in 
healthcare, which may be reduced through evidence based choice, use and 
interpretation of diagnostic tests.  We hypothesized that diagnostic errors are reduced 
through evidence based choice, use and interpretation of diagnostic tests. 
Study Design: Retrospective cohort study. 
Setting & Population: Diagnostic test studies.   
Selection criteria for Studies: Publications from 1966 to 2008 retrieved from 
Medline. 
Intervention: The quality of diagnostic accuracy studies tool (QUADAS) tool. 
Outcomes: Number and coverage of diagnostic studies in Nephrology, and the 
methodological quality of test accuracy subset. 
Results: Fewer diagnostic studies were published in Nephrology than other areas of 
internal medicine, although the proportion of total citations that were diagnostic 
studies (4.9%, sd±2.8) was not statistically different to other specialties (P=0.2). 
Within Nephrology, some topic areas (e.g. urinary tract infections) were over 
represented while others (e.g. acute kidney injury) had relatively few diagnostic 
studies (Range: 2.7% to 12.5%). Examining the randomly selected subset of studies 
that were diagnostic test accuracy studies (120) showed variable quality. Ninety-seven 
percent (116/120) of studies adequately described index test procedure, but only 27% 
(32/120) of studies adequately blinded investigators to results of index tests and 36% 
(43/120) to results of reference tests. The quality of nephrology diagnostic test 
accuracy studies has not substantially improved over the past 30 years.  
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Limitations:  When comparing Nephrology with other specialties, some potential 
inequalities of scale could not be addressed, which may influence research output 
results across specialties. 
Conclusions: Diagnostic research in Nephrology is published less frequently than 
most other medical specialties. The quality of diagnostic test accuracy studies that are 
published is variable and leaves room for improvement.  
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Introduction 
Optimal patient outcomes depend on clinician’s use and interpretation of diagnostic 
tests to trigger appropriate management algorithms for example a primary care 
physician may monitor a patient’s estimated glomerular filtration rate to decide the 
optimal timing for referral to a nephrology service for assessment and 
multidisciplinary management of chronic kidney disease.  There is empiric evidence 
to show that poor study design leads to biased results and overestimation of test 
performance.1-3 Diagnostic errors are an important source of preventable harm in 
healthcare, and are often under-recognised.4,5 Approximately 5% of autopsies reveal 
lethal conditions which may have been prevented with a correct diagnosis,6 and in the 
USA alone approximately 40 000-80 000 deaths occur annually due to misdiagnosis.7 
In one study, harms relating to diagnostic error were more likely to be considered 
negligent and result in serious disability compared to drug related error.8 Tort claims 
for diagnostic errors are nearly twice as common as claims for medication errors and 
result in the largest payouts.9  
Diagnostic test accuracy studies provide the best evidence for clinicians to establish 
the operating characteristics of a test. In contrast to randomised controlled trials of 
interventions, little is known about the frequency of publication or quality of 
diagnostic test accuracy studies. What is known is limited to  specific medical 
conditions such as melanoma,10 breast cancer,11 lung cancer12 and bowel cancer,13 
which all demonstrate significant variability in study quality. To our knowledge, no 
study has examined diagnostic research from a broader perspective such as at a 
discipline or specialty level. We hypothesized that diagnostic errors are reduced 
through evidence based choice, use and interpretation of diagnostic tests. 
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The aims of our study were to estimate the number of diagnostic studies published in 
Nephrology and to compare this with other specialties of internal medicine, to 
describe the coverage of diagnostic studies within Nephrology by topic area, and to 
estimate the quality of design and reporting of diagnostic test accuracy studies in 
Nephrology over time. 
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Methods  
Firstly, we identified diagnostic studies by searching MEDLINE via the OvidSP 
platform. We identified appropriate specialty-based medical subject headings (MeSH 
terms), to search for all citations relevant to thirteen major specialties of internal 
medicine and then limited results to the years 1966 to 2008. MeSH terms used were: 
exp Cardiovascular Diseases/, exp Digestive System Diseases/, exp Nervous System 
Diseases/, exp Immunologic Diseases/, exp Neoplasms/, exp Respiratory Tract 
Diseases/, exp Endocrine Diseases/, exp Musculoskeletal Diseases/, exp Nutritional 
and Metabolic Diseases/, exp Skin and Connective Tissues Diseases/, exp Hemic and 
Lymphatic Diseases/, (exp Bacterial Infections/ OR exp Mycoses/ OR exp Virus 
Diseases/ OR exp Parasitic Diseases/), (exp Kidney Diseases/ OR exp Urolithiasis/ 
OR Urinary tract infections/ OR Pyuria/ OR Bacteriuria/ OR Proteinuria/ OR exp 
Renal Replacement Therapy/). We chose the upper limit of 2008 to reduce any 
selection bias that might arise due to potential differences among medical speciality 
journals in time lag from publication to indexing by MEDLINE (last search December 
2009). To estimate the number and proportion of the total citations that were 
diagnostic studies, the filter “diagnosis (optimized)” was applied using MEDLINE’s 
clinical queries option ( this filter applies the following search terms and Boolean 
operators: sensitiv*.mp OR predictive value*.mp OR accurac*.tw).14 We used a 
Pearson χ2 test to determine if the proportion of diagnostic studies was statistically 
different amongst medical specialties.  
To evaluate the coverage of diagnostic studies within Nephrology, we identified the 
relevant MeSH terms for eleven major areas of Nephrology and used these terms in a 
new MEDLINE search. MeSH terms used were: exp Renal Tubular Transport, Inborn 
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Errors/, exp Renal Insufficiency, Acute/, (Renal Insufficiency/ OR Kidney Failure/ 
OR exp Renal Insufficiency, Chronic/), Diabetic Nephropathy/, (Nephritis OR exp 
Glomerulonephritis/ OR exp Nephrosis/), Renal Dialysis/, exp Peritoneal Dialysis/, 
Kidney Transplantation/, exp Urolithiasis/, (Urinary Tract Infections/ OR Bacteruria/ 
OR Pyuria/), exp Renal Artery Obstruction/. Again, these results were limited to the 
years 1966 to 2008 and filtered using “diagnosis (optimized)”.  
Secondly, from the larger pool of diagnostic studies, we randomly selected a subset 
that were diagnostic test accuracy studies. We defined diagnostic test accuracy studies 
as those studies that aimed to accurately classify people with and without the target 
condition, by comparing results of a test or a series of tests with a reference standard. 
To assess quality of design and reporting of the evidence base for comparative 
diagnostic test accuracy studies, we randomly selected 600 studies from our search 
results (approximately 2.5% of the total) and from these two authors (RGMG, BLN) 
working independently screened the titles and abstracts of diagnostic studies, to 
identify which of these studies were the subset that were diagnostic test accuracy 
studies. We discarded other diagnostic studies, which did not attempt to estimate 
comparative accuracy, including studies of genetic techniques, microbial sensitivities 
and overview articles. From this sample, the quality of the diagnostic test accuracy 
studies was assessed by the fourteen components of the quality of diagnostic accuracy 
studies (QUADAS) tool.15 QUADAS was developed as a quality assessment tool for 
diagnostic test accuracy studies; if a diagnostic test accuracy study poorly reports 
these parameters, it may be associated with a biased estimate of diagnostic test 
accuracy.1-3 The quality in each QUADAS domain was graded as high, low or unclear 
for each study according to the guidance presented in the original QUADAS paper.15 
Change in methodological quality over time (grouped by decade, and stratified into 
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low/unclear versus high quality) was assessed by ordinal logistic regression and 
likelihood ratio test statistics using Stata software (Stata11, http://www.stata.com/). 
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Results 
Quantity of diagnostic studies 
Figure 1 illustrates the selection of studies for inclusion in this study. Figure 2 
illustrates the number of citations for diagnostic studies, in thirteen internal medicine 
specialties from 1966 to 2008. The number of diagnostic studies published across all 
specialties increased over time, but there were fewer diagnostic studies published in 
Nephrology compared to all other specialties. The mean number of diagnostic studies 
published per specialty was 59 764 (standard deviation; sd ± 34 855). Oncology 
published the greatest number of diagnostic studies for each calendar year since 1975, 
and overall (142 467 total), whereas Nephrology published the fewest diagnostic 
studies between years 1992 and 2007, and a total of 22 230 studies between 1966 and 
2008.  
When we allowed for differences in relative size of medical specialties,  by 
calculating the proportion of diagnostic studies compared with total citations, the 
relative standing of Nephrology improved somewhat, as shown in Figure 3. The 
proportion of total citations that were diagnostic studies increased over time for all 
specialties. The proportion of total citations that were diagnostic studies in 
Nephrology was 4.9%, sd±2.8, which was not statistically different to that in other 
specialties P=0.2, range: Rheumatology 4%, Infectious diseases 7.6%.  
Within Nephrology, the topic areas of diabetic nephropathy, renal artery stenosis and 
urinary tract infection were covered by a greater proportion of diagnostic studies than 
the overall Nephrology mean 4.9%, range: acute kidney injury 2.7%, urinary tract 
infections 12.5%. Chronic kidney disease, kidney transplantation, haemodialysis, 
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glomerulonephritis, peritoneal dialysis, urolithiasis, acute kidney injury and renal 
tubular transport were under-represented (see Figure 4).  
Quality of diagnostic test accuracy studies in Nephrology 
Of the 600 papers randomly selected for further assessment, 480 studies primarily 
examined genetic techniques, microbial sensitivities or were overview articles about 
tests. Only 120 (20%) studies were designed as diagnostic test accuracy studies and 
were further assessed for design and reporting quality. These 120 studies were 
published across 75 journals, with only five journals publishing four or more studies: 
Radiology (6), American Journal of Radiology (5), Transplantation (5), Kidney 
International (4) and Journal of Clinical Microbiology (4). These studies investigated 
a range of diagnostic modalities: imaging (39), biochemical (19), pathological (27), 
risk modelling (12), and other (23).   
Of the 120 diagnostic test accuracy studies assessed, quality was mixed. Ninety-seven 
percent (116/120) of studies adequately described index test procedure, in 95% 
(114/120) of studies, the index test appropriately did not form part of the reference 
standard, and 90% (108/120) included a spectrum of patients that was representative 
of those seen in practice. However, for many other QUADAS domains, quality was 
suboptimal. Only 27% (32/120) of studies adequately blinded investigators to results 
of index tests and 36% (43/120) to results of reference tests. For 70% (84/120) and 
63% (75/120) of studies respectively, blinding of the index and reference standard 
tests was unclear. The time interval between administering index and reference tests 
was unclear in 42% (50/120) of studies. Ten of the fourteen quality parameters of the 
QUADAS tool did not significantly improve between 1966 and 2008 (see Figure 5). 
Because of the small number of eligible studies, the confidence intervals around these 
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estimates are large. The four parameters that did improve over time included: Q2 
reporting of selection criteria (P< 0.001), Q4 acceptable delay between tests (P= 
0.02), Q9 description of reference standard test procedure (P= 0.01), and Q12 same 
clinical data available as when used in practice (P= 0.01). 
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Discussion  
Overall, the evidence base supporting informed choice of diagnostic tests in 
Nephrology appears weak. Although the number of diagnostic studies in Nephrology 
has increased over time, there are fewer diagnostic studies published in Nephrology 
than any other medical specialty over the past 40 years. This finding is in context 
given the relatively low publication output of Nephrology in general, across all study 
types. When adjusted for relative specialty size, using a proportional rather than 
absolute number of publications, the performance of Nephrology improved, but 
remained lower than average across all specialties. Within Nephrology, coverage was 
patchy and did not appear to be related to clinical importance of the topic or disease 
burden. Some topic areas were over represented such as diabetic nephropathy and 
renal artery stenosis, but others were under-represented, such as glomerulonephritis 
and acute kidney injury. Overall design and reporting quality was mixed, with many 
important methodological features of diagnostic accuracy studies poorly designed and 
reported, and perhaps most importantly, no strong signal of improvements over time. 
This is the first study that we are aware of to have examined the quantity and 
coverage of diagnostic studies and quality of diagnostic test accuracy studies across a 
medical specialty. This is important because it reflects the perspective of users of 
research working in clinical practice, who have to assess and make use of tests in a 
variety of clinical situations and disease states. Other studies, which have examined 
the quality and relevance of diagnostic test publications, have done so from a limited 
perspective of diagnosing a specific disease state.7-10 A similar study which focussed 
on interventional research and evaluated the quantity and quality of randomised 
controlled trials in Nephrology showed comparable results to our study.16 In 2002, the 
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number of randomised trials published in Nephrology was lower compared to all other 
specialties of internal medicine and the quality of those studies published was 
suboptimal.  
It has been demonstrated consistently that studies with suboptimal design and 
reporting features tend to overestimate the performance characteristics of the index 
test being evaluated. When used in clinical practice, such studies will therefore tend to 
lead to unrecognised misclassification of disease by clinicians, leading to additional 
unnecessary tests and treatment and inappropriately withheld tests and treatment, 
depending upon the direction and magnitude of the error. Our study has shown that 
poor design features are highly prevalent in diagnostic test accuracy studies published 
in Nephrology and are not improving. These findings highlight the importance of high 
quality reporting and the endorsement of reporting guidelines for specific study 
designs; for diagnostic test accuracy studies these are the standards for the reporting 
of diagnostic accuracy studies (STARD) guidelines.17 Currently only two of the 246 
journals that support the use of the STARD statement are Nephrology journals,18 even 
though five Nephrology journals support the equivalent guideline for randomised 
controlled trials – the CONSORT statement.19  
As a descriptive study, there are potential limitations to our work. Our choice of 
search terms to identify publications in medical specialty areas was not as 
comprehensive in scope as a systematic review, but mirrors other similar work.16 We 
chose the clinical queries filter “diagnosis (optimized)” to try to achieve a balance of 
sensitivity and specificity in retrieval of studies. The original study which developed 
this filter showed that it had a sensitivity of 93% and a specificity of 92%, compared 
to a gold standard of hand searching,1 and therefore some true diagnostic test accuracy 
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studies may have been missed (false negative) or non-diagnostic accuracy studies 
included (false positive), although this error is likely to be non-differential across the 
medical specialties. While we adjusted our estimates for the total number of citations 
within each specialty, we did not address other potential inequalities of scale across 
specialties, such as number of patients eligible for study participation, and the number 
of new interventions, tests and devices. Nor did we adjust for the number of tests 
performed in practice. It may be that if we were able to allow for such differences, we 
would have found different results when comparing across the specialties. Globally, 
the range of conditions seen by Nephrologists will vary and there may be some 
conditions, which we have not considered. Additionally, as we did not apply the 
QUADAS tool to diagnostic test accuracy studies in other specialties, and as our study 
is unique, we cannot make comparisons about quality across different medical 
specialties. 
Given the findings of our study, what can be done to improve the quantity and quality 
of diagnostic test accuracy studies in Nephrology? Greater endorsement of the 
STARD statement17 and quality assessment tools such as the QUADAS tool,15 by 
journals and peer reviewers would be helpful; as would further efforts to improve 
awareness of design and reporting quality issues, in the design and analysis of 
diagnostic tests accuracy studies. One promising initiative, has recently sought to 
improve clinical research skills amongst Nephrologists.18 We would also suggest that 
learned Colleges and Societies promote the uptake of epidemiological and general 
research methodology training amongst its members, particularly trainees, which 
could build capacity for the future. Further research should aim to assess the 
effectiveness of these educational efforts.  
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In conclusion, we have shown that diagnostic studies in Nephrology are published 
less frequently than in most other medical specialties. The quality of diagnostic test 
accuracy studies that are published is variable and leaves room for improvement. 
Most importantly, these findings should challenge researchers and funding bodies to 
improve standards of the diagnostic test accuracy evidence base in our specialty. 
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Figures and Legends 
Figure 1. Flow chart of study selection process. 
Figure 2. The number of diagnostic studies published in Nephrology and twelve other 
internal medicine specialties by calendar year.  
Figure 3. The proportion of total citations that were diagnostic studies in Nephrology 
and twelve other internal medicine specialties by calendar year. 
Figure 4. The number of diagnostic studies published in eleven topic areas of 
Nephrology compared to the total number of citations.  
Note: The solid line represents the mean proportion of total citations in Nephrology 
that were diagnostic studies (4.9%). 
Figure 5. Proportion of high quality diagnostic test accuracy studies for each 
QUADAS domain.15 
Note: Each numbered plot refers to the corresponding QUADAS item number. All P 
values were calculated using likelihood ratio test statistics.  
